A brief project overview is enough for the initial conversation. Confidential data can be shared securely after the call and, if required, under an NDA.
Not sure whether your data are ready?
Your team tests the prioritized candidates using the most appropriate experimental assay.
You receive a ranked candidate table, mutation-level rationale, interface maps, confidence notes, and a focused validation panel.
5. Receive a decision-ready shortlist
We compare candidates using the agreed structural and interaction workflow. Each variant is evaluated consistently for predicted effects on the binding interface, molecular contacts
4.Analyze and rank candidates
Before calculation, we review chain identities, sequence and structure coverage, missing residues, interface definition, ligand or cofactor states, and relevant assay context.
3. Confirm data readiness
Provide what you already have:
PDB or mmCIF structures, FASTA sequences, and optional assay data.
2. Share your available data
Tell us what your team needs to decide: which antibody variants to express, test, or advance.
We translate this into a focused comparison plan and agree on the scope, timeline, required inputs
- Define the research question
One decision at a time.
A narrow scientific question creates a report that is easier to validate and easier to use.
The result answers a practical question: which candidates deserve expression, measurement, and comparison in the next wet-lab cycle?
We compare the results with the computational ranking, explain agreements and discrepancies, and refine the next round when follow-up analysis is included in the project scope.